BPG is committed to discovery and dissemination of knowledge
Article Citation
Zhu JJ, Wilding JPH, Gu XS. Combining GLP-1 receptor agonists and SGLT-2 inhibitors for cardiovascular disease prevention in type 2 diabetes: A systematic review with multiple network meta-regressions. World J Diabetes 2024; 15(10): 2135-2146 [PMID: 39493569 DOI: 10.4239/wjd.v15.i10.2135]
Please LOGIN to submit a new comment.
Write to the Help Desk